The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
22 Pages - GLDATA58157
$250.00

Summary

The Translational Genomics Research Institute (TGen), formerly known as Arizona Bioscience and Bio-medicine Institute, is a non-profit organization that focuses on developing earlier diagnostics and treatments. The organization conducts clinical trials to investigate new chemical agents for the treatment of pancreatic cancer, breast cancer, leukemia, prostate cancer, lung cancer, and melanoma and incorporate novel tools for identifying patients' genomic characteristics for a more targeted approach. TGen employs advances from the human genome project to develop prognostics, diagnostics, and therapies for treatment of neurological disorders, cancer, diabetes and other complex diseases. The organization also conducts research programs for finding new therapies for the treatment of autism, breast cancer, diabetes, gastric cancer, melanoma, and prostate cancer. It operates through its research units. TGen is headquartered in Phoenix, Arizona, the US.

The Translational Genomics Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Translational Genomics Research Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TGen Enters into Research Agreement with Baylor Research Institute 11
BIO5 Oro Valley Enters Into Co-Development Agreement With TGen For Alzheimer’s Disease 12
Virginia G. Piper Cancer Center And TGen Enter Into Co-Development Agreement With Samuel Oschin Comprehensive Cancer Institute 13
Life Technologies Enters Into Joint Venture With Fox Chase, Scripps Health And Translational Genomics Research Institute 14
Asuragen Enters Into An Agreement With The Translational Genomics Research Institute 16
Translational Genomics Research Institute Enters Into Agreement With Van Andel Research Institute 17
Geisinger Health Enters Into Research Agreement With The Translational Genomics 18
Licensing Agreements 19
Oncoholdings Receives License For ONCO-101 From The Translational Genomics Research Institute 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Translational Genomics Research Institute, Deals By Therapy Area, 2010 to YTD 2016 8
The Translational Genomics Research Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
TGen Enters into Research Agreement with Baylor Research Institute 11
BIO5 Oro Valley Enters Into Co-Development Agreement With TGen For Alzheimer’s Disease 12
Virginia G. Piper Cancer Center And TGen Enter Into Co-Development Agreement With Samuel Oschin Comprehensive Cancer Institute 13
Life Technologies Enters Into Joint Venture With Fox Chase, Scripps Health And Translational Genomics Research Institute 14
Asuragen Enters Into An Agreement With The Translational Genomics Research Institute 16
Translational Genomics Research Institute Enters Into Agreement With Van Andel Research Institute 17
Geisinger Health Enters Into Research Agreement With The Translational Genomics 18
Oncoholdings Receives License For ONCO-101 From The Translational Genomics Research Institute 19
The Translational Genomics Research Institute, Key Employees 20
The Translational Genomics Research Institute, Other Locations 21
The Translational Genomics Research Institute, Subsidiaries 21

List of Figures
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Translational Genomics Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Translational Genomics Research Institute, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838